Voltage-gated sodium channel (TTX-sensitive subtypes NaV1.1, NaV1.2, NaV1.3, NaV1.4, NaV1.6, and NaV1.7) (NaV (TTX-sensitive))

Voltage-gated sodium channels (NaVs) are essential transmembrane proteins that facilitate the rapid influx of sodium ions into cells in response to membrane depolarization, a process fundamental to the initiation and propagation of action potentials in excitable tissues (Catterall, W. A., 2000, PMID: 10751120). The tetrodotoxin (TTX)-sensitive group specifically includes subtypes NaV1.1, 1.2, 1.3, 1.4, 1.6, and 1.7, which are primarily localized in the central nervous system, peripheral nervous system, and skeletal muscle (Goldin, A. L., 2001, PMID: 11585316). These channels play critical roles in sensory perception, motor control, and cognitive function. Mutations in the genes encoding these subunits, such as SCN1A or SCN9A, are linked to various channelopathies including Dravet syndrome, familial hemiplegic migraine, and congenital insensitivity to pain (Meisler, M. H., & Kearney, J. A., 2005, PMID: 15630428). Pharmacologically, these channels are targeted by local anesthetics, anti-epileptics, and anti-arrhythmics to manage seizures and chronic pain. A major challenge in drug development is achieving subtype selectivity to avoid off-target effects on the TTX-resistant NaV1.5 subtype, which is critical for cardiac conduction (Bagal, S. K., et al., 2015, PMID: 25379702).

Other names

Tetrodotoxin-sensitive voltage-gated sodium channelsSodium channel protein type 1 subunit alpha (SCN1A)Sodium channel protein type 2 subunit alpha (SCN2A)Sodium channel protein type 3 subunit alpha (SCN3A)Sodium channel protein type 4 subunit alpha (SCN4A)Sodium channel protein type 8 subunit alpha (SCN8A)Sodium channel protein type 9 subunit alpha (SCN9A)VGSCType I/II/III/IV/VIII/IX voltage-gated sodium channels

Drugs targeting these channels typically act as pore blockers or allosteric modulators that stabilize the inactivated state of the channel (Catterall, W. A., 2012, PMID: 22448276). By binding to the local anesthetic receptor site within the alpha-subunit, these agents inhibit the rapid influx of sodium ions, thereby reducing the frequency and synchronization of action potential firing in hyper-excitable tissues such as epileptic foci or damaged peripheral nerves (StatPearls, 2023, NBK532924).